These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 28381184)
1. Integrated Cox's model for predicting survival time of glioblastoma multiforme. Ai Z; Li L; Fu R; Lu JM; He JD; Li S Tumour Biol; 2017 Apr; 39(4):1010428317694574. PubMed ID: 28381184 [TBL] [Abstract][Full Text] [Related]
2. Cancer survival classification using integrated data sets and intermediate information. Kim S; Park T; Kon M Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860 [TBL] [Abstract][Full Text] [Related]
3. A functional polymorphism in the pre‑miR‑146a gene influences the prognosis of glioblastoma multiforme by interfering with the balance between Notch1 and Notch2. Liu R; Li W; Wu C Mol Med Rep; 2015 Oct; 12(4):5475-81. PubMed ID: 26165719 [TBL] [Abstract][Full Text] [Related]
4. The functional Aquaporin 1 -783G/C-polymorphism is associated with survival in patients with glioblastoma multiforme. El Hindy N; Rump K; Lambertz N; Zhu Y; Frey UH; Bankfalvi A; Siffert W; Sure U; Peters J; Adamzik M; Sandalcioglu IE J Surg Oncol; 2013 Dec; 108(7):492-8. PubMed ID: 24014128 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans. Hung KS; Howng SL J Neurosurg; 2003 Nov; 99(5):886-92. PubMed ID: 14609169 [TBL] [Abstract][Full Text] [Related]
6. Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme. Bao ZS; Zhang CB; Wang HJ; Yan W; Liu YW; Li MY; Zhang W CNS Neurosci Ther; 2013 Sep; 19(9):714-20. PubMed ID: 23663361 [TBL] [Abstract][Full Text] [Related]
7. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens. Ilhan-Mutlu A; Wöhrer A; Berghoff AS; Widhalm G; Marosi C; Wagner L; Preusser M J Neurooncol; 2013 May; 112(3):347-54. PubMed ID: 23420397 [TBL] [Abstract][Full Text] [Related]
8. A long non-coding RNA signature in glioblastoma multiforme predicts survival. Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844 [TBL] [Abstract][Full Text] [Related]
9. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme. Huang YT; Hsu T; Kelsey KT; Lin CL Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983 [TBL] [Abstract][Full Text] [Related]
11. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme. El Hindy N; Bachmann HS; Lambertz N; Adamzik M; Nückel H; Worm K; Zhu Y; Sure U; Siffert W; Sandalcioglu IE J Neurosurg; 2011 Jun; 114(6):1631-9. PubMed ID: 21250804 [TBL] [Abstract][Full Text] [Related]
12. Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme. Simon M; Ludwig M; Fimmers R; Mahlberg R; Müller-Erkwoh A; Köster G; Schramm J Neurosurgery; 2006 Nov; 59(5):1078-85; discussion 1085. PubMed ID: 17016233 [TBL] [Abstract][Full Text] [Related]
13. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy? Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. Henriksen M; Johnsen KB; Andersen HH; Pilgaard L; Duroux M Mol Neurobiol; 2014 Dec; 50(3):896-913. PubMed ID: 24619503 [TBL] [Abstract][Full Text] [Related]
15. An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis. Xiong J; Bing Z; Su Y; Deng D; Peng X PLoS One; 2014; 9(5):e98419. PubMed ID: 24871302 [TBL] [Abstract][Full Text] [Related]
16. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872 [TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers for glioblastoma multiforme. Quddusi A; Shamim MS J Pak Med Assoc; 2019 Jun; 69(6):913-914. PubMed ID: 31201406 [TBL] [Abstract][Full Text] [Related]
18. The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme. Sippl C; Teping F; Ketter R; Braun L; Tremmel L; Schulz-Schaeffer W; Oertel J; Urbschat S World Neurosurg; 2019 Dec; 132():e900-e908. PubMed ID: 31351207 [TBL] [Abstract][Full Text] [Related]
19. An integrated analysis of germline and somatic, genetic and epigenetic alterations at 9p21.3 in glioblastoma. Feng J; Kim ST; Liu W; Kim JW; Zhang Z; Zhu Y; Berens M; Sun J; Xu J Cancer; 2012 Jan; 118(1):232-40. PubMed ID: 21713760 [TBL] [Abstract][Full Text] [Related]
20. Role of the GNAS1 T393C polymorphism in patients with glioblastoma multiforme. El Hindy N; Lambertz N; Bachmann HS; Frey UH; Adamzik M; Zhu Y; Sure U; Siffert W; Sandalcioglu IE J Clin Neurosci; 2011 Nov; 18(11):1495-9. PubMed ID: 21924916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]